Better Preoperative Coordination of Care Needed for Patients With Lung Cancer

Share this content:
Study finds lung cancer patients miss critical diagnostic tests and often wait too long for treatment.
Study finds lung cancer patients miss critical diagnostic tests and often wait too long for treatment.

Patients who undergo surgery for lung cancer often wait too long to receive treatment, and many do not receive critical diagnostic tests that are necessary to determine the best possible treatment, according to a study published in the August 2015 issue of The Annals of Thoracic Surgery.1

The 5-year relative survival rate of patients diagnosed with lung cancer remains below 20%, and has not changed significantly over the past 30 years.2 Most patients who survive more than 5 years have had surgery as part of their treatment, yet fewer than half of patients who undergo surgery for lung cancer survive 5 years.3

A group of researchers from Baptist Centers for Cancer Care, in Southaven, MS, and Memphis, TN,  and the University of Memphis in Tennessee, led by Raymond Osarogiagbon, MBBS and Nicolas Faris, MDiv, retrospectively reviewed the clinical records of all recipients of lung resection surgery at two hospitals over 42 months.

They classified all lung cancer-related procedures into five points of care: lesion detection, diagnostic biopsy, radiologic staging, invasive staging, and treatment, and analyzed the duration between points and what steps were taken to determine the best possible treatment.

Of 614 eligible patients, 92% had lung cancer, 5% had a non-lung primary tumor, and 3% had a benign lesion. Only 6% received preoperative therapy.

Twenty-seven percent had no preoperative diagnostic procedure; 22% did not receive PET/CT imaging scans; and 88% did not receive an invasive staging test. Only 10% received the recommended combination of CT, PET/CT, and invasive staging.

RELATED: Adding Radiotherapy to Neoadjuvant Chemo Not Beneficial for Stage 3A/N2 Lung Cancer

The researchers also found that it took anywhere from 43 and 189 days from when lesions were initially detected to when patients underwent surgery.

The median wait from initial detection to diagnostic biopsy was 28 days, and from diagnostic biopsy to surgery, 40 days. In an interview with Cancer Therapy Advisor, Dr. Osarogiagbon said “delay in diagnosis and treatment is extremely unpleasant to patients and their home caregivers.”

Page 1 of 2

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs